Screener
CVS Health CVS Medicaid Product Line — Premium deficiency reserve
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by CVS Health in its filing.
Tagged under the XBRL concept cvs:PremiumDeficiencyTestingExpenseShortDurationContractAmount.
The source filing: CVS Health’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 6:33 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000064803-26-000098
During the second quarter of 2026, the Company recorded a premium deficiency reserve of $15 million to health care costs related to one state in its Medicaid product line. The Company did not establish any other premium deficiency reserves during the three and six months ended June 30, 2026.
Item 1.Financial Statements
FAQ
- What is CVS Health's medicaid product line — premium deficiency reserve?
- CVS Health (CVS) reported medicaid product line — premium deficiency reserve of $15M in Q2 2026.
- What does medicaid product line — premium deficiency reserve mean?
- This metric represents the balance sheet liability established when the expected future costs of fulfilling obligations under existing Medicaid insurance contracts exceed the related unearned premiums. It serves as a buffer to ensure the company maintains sufficient capital to cover anticipated losses on these specific insurance policies. Monitoring this reserve provides insight into the long-term actuarial health and potential future liabilities associated with the company's Medicaid product offerings.
Ask your AI about CVS Health's medicaid product line — premium deficiency reserve.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude